HLA Evolutionary Divergence as a Prognostic Marker for AML Patients Undergoing Allogeneic Stem Cell Transplantation.

AML HLA evolutionary divergence acute myeloid leukemia allogeneic stem cell transplantation graft-versus-leukemia effect

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
08 Jul 2020
Historique:
received: 15 06 2020
revised: 03 07 2020
accepted: 06 07 2020
entrez: 12 7 2020
pubmed: 12 7 2020
medline: 12 7 2020
Statut: epublish

Résumé

The diversity of human leukocyte antigens (HLAs) enables the presentation of immense repertoires of peptides, including tumor-associated antigens (TAAs). As a surrogate for immunopeptidome diversity, the HLA evolutionary divergence (HED) between individual HLA alleles might directly define the ability to present TAAs, a prerequisite for graft-versus-leukemia effects. We therefore analyzed the impact of HED on survival within a cohort of 171 acute myeloid leukemia (AML) patients after matched donor allogeneic hematopoietic stem cell transplantation (HSCT). Low HED (<25th percentile) of HLA class I (HED

Identifiants

pubmed: 32650450
pii: cancers12071835
doi: 10.3390/cancers12071835
pmc: PMC7408841
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : WA 4608/1-2
Organisme : Deutsche Forschungsgemeinschaft
ID : EXC2180-390900677
Organisme : Wilhelm Sander-Stiftung
ID : 2016.177.2
Organisme : José Carreras Leukämie-Stiftung
ID : DJCLS 05 R/2017
Organisme : Fortüne program, University of Tübingen
ID : 2581-0-0
Organisme : Fortüne program, University of Tübingen
ID : 2451-0-0

Références

Nat Rev Cancer. 2017 Apr;17(4):209-222
pubmed: 28233802
Nat Rev Clin Oncol. 2012 Oct;9(10):579-90
pubmed: 22949046
Blood. 2010 Jan 21;115(3):453-74
pubmed: 19880497
Nature. 1975 Jul 3;256(5512):50-2
pubmed: 1079575
Br J Haematol. 2001 Mar;112(4):988-94
pubmed: 11298597
Immunity. 2017 Feb 21;46(2):315-326
pubmed: 28228285
Int J Cancer. 2008 Feb 1;122(3):486-94
pubmed: 17955486
Expert Rev Hematol. 2017 Aug;10(8):745-752
pubmed: 28644756
Blood Cancer J. 2014 Mar 28;4:e197
pubmed: 24681961
Blood. 2017 Jan 26;129(4):424-447
pubmed: 27895058
Blood. 2013 Sep 12;122(11):1963-73
pubmed: 23777765
Science. 2017 Apr 14;356(6334):200-205
pubmed: 28408606
Cell. 2017 Nov 30;171(6):1259-1271.e11
pubmed: 29107330
Evolution. 2011 Aug;65(8):2380-90
pubmed: 21790583
Nucleic Acids Res. 2020 Jan 8;48(D1):D948-D955
pubmed: 31667505
Nat Genet. 1997 Sep;17(1):11-2
pubmed: 9288086
Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11260-4
pubmed: 12177415
Genome Med. 2017 Apr 19;9(1):34
pubmed: 28420421
Blood. 2006 Sep 15;108(6):2106-13
pubmed: 16757687
Leukemia. 2015 Mar;29(3):647-59
pubmed: 25092142
Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):E166-75
pubmed: 25548167
J Immunol. 2013 Dec 15;191(12):5831-9
pubmed: 24190657
Leukemia. 2012 Feb;26(2):312-22
pubmed: 21860431
Nat Med. 2019 Nov;25(11):1715-1720
pubmed: 31700181
Blood. 2008 Dec 1;112(12):4371-83
pubmed: 19029455
J Mol Biol. 2003 Aug 15;331(3):623-41
pubmed: 12899833
Mol Biol Evol. 2018 Sep 1;35(9):2145-2158
pubmed: 29893875
Biol Blood Marrow Transplant. 2008 Jan;14(1):28-35
pubmed: 18158958
Science. 1974 Sep 6;185(4154):862-4
pubmed: 4843792
J Immunol. 2009 May 15;182(10):5938-48
pubmed: 19414745
Nucleic Acids Res. 2018 Jan 4;46(D1):D754-D761
pubmed: 29155950
N Engl J Med. 2010 Nov 25;363(22):2091-101
pubmed: 21105791
Bone Marrow Transplant. 2012 Jun;47(6):749-56
pubmed: 21643021
Curr Opin Immunol. 2018 Apr;51:123-132
pubmed: 29567511
J Clin Oncol. 2002 Jan 15;20(2):405-12
pubmed: 11786567
Blood. 2007 Sep 15;110(6):1924-32
pubmed: 17505014
PLoS Genet. 2017 Jun 26;13(6):e1006862
pubmed: 28650991
Blood. 2008 Feb 15;111(4):2476-84
pubmed: 18045967
Nat Med. 2005 Nov;11(11):1244-9
pubmed: 16227991
Clin Cancer Res. 2003 Oct 1;9(12):4296-303
pubmed: 14555498
N Engl J Med. 2018 Dec 13;379(24):2330-2341
pubmed: 30380364
Nat Rev Immunol. 2018 Oct;18(10):635-647
pubmed: 30057419
Science. 2018 Feb 2;359(6375):582-587
pubmed: 29217585

Auteurs

Malte Roerden (M)

Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, 72076 Tübingen, Germany.
Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, 72076 Tübingen, Germany.

Annika Nelde (A)

Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, 72076 Tübingen, Germany.
Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, 72076 Tübingen, Germany.
Institute for Cell Biology, Department of Immunology, University of Tübingen, 72076 Tübingen, Germany.

Jonas S Heitmann (JS)

Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, 72076 Tübingen, Germany.
Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, 72076 Tübingen, Germany.

Reinhild Klein (R)

Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, 72076 Tübingen, Germany.

Hans-Georg Rammensee (HG)

Institute for Cell Biology, Department of Immunology, University of Tübingen, 72076 Tübingen, Germany.
German Cancer Consortium (DKTK), DKFZ Partner Site Tübingen, 72076 Tübingen, Germany.

Wolfgang A Bethge (WA)

Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, 72076 Tübingen, Germany.

Juliane S Walz (JS)

Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, 72076 Tübingen, Germany.
Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, 72076 Tübingen, Germany.
Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, 72076 Tübingen, Germany.

Classifications MeSH